Document Detail

Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup.
MedLine Citation:
PMID:  11602894     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The purpose of this study was to determine the role of fluorodeoxyglucose positron emission tomography (PET) in localizing disease in patients with colorectal cancer with radiologically occult symptomatology or increases in carcinoembryonic antigen (CEA) level. METHODS: Two hundred seventy-seven patients with colorectal cancer underwent PET scanning between November 1998 and September 2000 prompted by (1) increasing CEA level and nondiagnostic imaging or (2) symptoms with normal CEA level and nondiagnostic imaging. PET results were correlated with operative findings/histology, clinical follow-up data, and CEA level to determine PET's accuracy in determining the source of symptoms or CEA. RESULTS: Fifteen patients had increasing CEA levels, and 14 had abnormal PET. Two of these 14 were denied exploration because PET suggested widely metastatic disease. Nine patients underwent exploration with curative intent. In 1 patient, recurrence was not pathologically confirmed (false-positive rate, 8%). Two had disease beyond that predicted by PET, and 6 underwent complete resection and normalized their CEA levels. Four symptomatic patients with normal CEA levels and negative x-rays had abnormal PET; at exploration, 3 had no evidence of recurrence. CONCLUSIONS: PET imaging can often accurately localize the source of radiologically occult increases in CEA level and select that subset of patients eligible for therapeutic laparotomy. Symptomatic, PET-positive patients with normal CEA levels frequently undergo nontherapeutic laparotomy, and PET findings should be interpreted with caution in these patients.
E E Zervos; B D Badgwell; W E Burak; M W Arnold; E W Martin
Related Documents :
6435914 - Reactivation of serum creatine kinase isoenzyme bb in patients with malignancies.
10561764 - The outcome of trial off catheter after acute retention of urine.
21529844 - Autonomic dysfunction in pd: a window to early detection?
1943114 - Rhabdomyosarcoma of the bladder and prostate in children.
16776624 - Lack of association between alpha2b-adrenergic receptor polymorphism and risk of resten...
23253044 - Auto-immune thyroid stigma in vitiligo: multivariate analysis indicates intricated path...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Surgery     Volume:  130     ISSN:  0039-6060     ISO Abbreviation:  Surgery     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2001-10-16     Completed Date:  2001-12-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  636-43; discussion 643-4     Citation Subset:  AIM; IM    
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoembryonic Antigen / analysis*
Colorectal Neoplasms / diagnosis,  radionuclide imaging*,  surgery
Fluorodeoxyglucose F18 / diagnostic use*
Middle Aged
Neoplasm Recurrence, Local
Tomography, Emission-Computed*
Reg. No./Substance:
0/Carcinoembryonic Antigen; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tu...
Next Document:  Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from s...